[
    [
        {
            "time": "2018-03-15",
            "original_text": "Lilly's lupus treatment succeeds in mid-stage trial",
            "features": {
                "keywords": [
                    "Lilly",
                    "lupus",
                    "treatment",
                    "succeeds",
                    "mid-stage",
                    "trial"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly's lupus treatment succeeds in mid-stage trial",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-24",
            "original_text": "J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit",
            "features": {
                "keywords": [
                    "J&J",
                    "JNJ",
                    "Platinum",
                    "Equity",
                    "LifeScan",
                    "Offer"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-24",
            "original_text": "J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit",
            "features": {
                "keywords": [
                    "J&J",
                    "JNJ",
                    "Platinum",
                    "Equity",
                    "LifeScan",
                    "Offer"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-11-21",
            "original_text": "Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trials",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "AstraZeneca",
                    "Alzheimer’s",
                    "Drug",
                    "Trials",
                    "Drop"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trials",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-11-26",
            "original_text": "CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks",
            "features": {
                "keywords": [
                    "CAH",
                    "FDA",
                    "Approval",
                    "Alzheimer's",
                    "Disease",
                    "Drug",
                    "Fails",
                    "VTVT",
                    "Tanks"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]